# Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005

> **NCT00544258** · PHASE1 · COMPLETED · sponsor: **Peplin** · enrollment: 8 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** PEP005

## Key facts

- **NCT ID:** NCT00544258
- **Lead sponsor:** Peplin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00544258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00544258, "Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00544258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*